Preclinical activity of melflufen (J1) in ovarian cancer.
Carlier C, Strese S, Viktorsson K, Velander E, Nygren P, Uustalu M, Juntti T, Lewensohn R, Larsson R, Spira J, De Vlieghere E, Ceelen WP, Gullbo J.
Carlier C, et al. Among authors: velander e.
Oncotarget. 2016 Sep 13;7(37):59322-59335. doi: 10.18632/oncotarget.11163.
Oncotarget. 2016.
PMID: 27528037
Free PMC article.